Effects of Antioxidants on Cardiovascular Risk Measures (Spice Study) (Spice)
Development of a Dynamic Model of Inflammation for Studying the Anti-inflammatory Effects of Culinary Spices in Human Participants
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
University Park, Pennsylvania, United States, 16802
- Penn State GCRC
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 30-65
- BMI 25-40
- Non tobacco user
- Resting BP < 160/100
- Fasting Glucose < 126 mg/dL
Exclusion Criteria:
- Tobacco use
- Use of female hormones
- Breastfeeding or planning to become pregnant during the study
- Use of lipid-lowering or blood pressure medications
- Chronic Inflammatory Disease or osteoarthritis requiring regular use of medication
- Chronic use of any form of anti-inflammatory or anti-psychotic drugs
- Use of daily aspirin or supplements (except stable dose of calcium)
- History of heart attack or stroke, renal or hepatic disease, implanted medical devices, gastrointestinal disease
- Allergy or intolerance to any study foods
- Injury to fingers or arms that would interfere with vascular and blood pressure measurements
- Inability to comply with study protocol
- Allergy to adhesives or latex
- Aerobic exercise exceeding 2 hours per week
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sham Comparator: No spice, no stress
Subject are given placebo capsules and told they contain an antioxidant concentrate
|
Placebo capsules
|
|
Sham Comparator: No Spice, Stress
Subjects are given placebo capsules and told they are receiving an equivalent amount of an antioxidant concentrate.
|
Placebo capsules
This is a psychological stressor that is used to invoked stress responses in human subjects.
Subjects are told they are taped and evaluated and deliver the speech in front of a trained panel of judges.
|
|
Experimental: Spice, no stress
|
14.5 g spice blend incorporated into a delivery meal including: cloves, cinnamon, oregano, rosemary, ginger, black pepper, paprika, garlic powder, and turmeric.
|
|
Experimental: Spice and Stress
|
This is a psychological stressor that is used to invoked stress responses in human subjects.
Subjects are told they are taped and evaluated and deliver the speech in front of a trained panel of judges.
14.5 g spice blend incorporated into a delivery meal including: cloves, cinnamon, oregano, rosemary, ginger, black pepper, paprika, garlic powder, and turmeric.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
IL-6 response to psychological stress at time points equal to and greater than 90 minutes post task
Time Frame: At baseline and intervals up to 2 hours following the stressor and 3.5 hours following the meal
|
At baseline and intervals up to 2 hours following the stressor and 3.5 hours following the meal
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Serum/plasma changes in antioxidant activity and their relationship to inflammation outcomes
Time Frame: At baseline and intervals up to 2 hours following the stressor and 3.5 hours following the meal
|
At baseline and intervals up to 2 hours following the stressor and 3.5 hours following the meal
|
|
Endothelial function measured by endopat
Time Frame: At baseline and 3.5 hours following the meal
|
At baseline and 3.5 hours following the meal
|
|
Platelet function measured by PFA-100
Time Frame: At baseline and specified intervals up to 2 hours following the stressor and 3.5 hours following the meal
|
At baseline and specified intervals up to 2 hours following the stressor and 3.5 hours following the meal
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Sheila G. West, PhD, Penn State
- Principal Investigator: Ann C. Skulas-Ray, B.S., Penn State
- Principal Investigator: Penny M. Kris-Etherton, PhD, RD, Penn State
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- G264
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.